Liu XH - Search Results

1

Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.

Cheng Y, Liu XQ, Fan Y, Liu YP, Liu Y, Liu Y, Ma LX, Liu XH, Li H, Bao HZ, Liu JJ, Zhang S, Wu CJ. Cheng Y, et al. Among authors: liu xh, liu jj, liu y, liu yp, liu xq. Future Oncol. 2016 Mar;12(6):789-99. doi: 10.2217/fon.15.346. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26838372 Clinical Trial.

2

RNAi screening identifies KAT8 as a key molecule important for cancer cell survival.

Zhang S, Liu X, Zhang Y, Cheng Y, Li Y. Zhang S, et al. Int J Clin Exp Pathol. 2013 Apr 15;6(5):870-7. Print 2013. Int J Clin Exp Pathol. 2013. PMID: 23638218 Free PMC article.

3

[Multi-factor retrospective study in 91 small cell lung cancer patients].

Liu Y, Zhu J, Liu X, Xin Y, Wang Y, Cheng Y. Liu Y, et al. Zhongguo Fei Ai Za Zhi. 2014 Aug 20;17(8):588-95. doi: 10.3779/j.issn.1009-3419.2014.08.02. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25130964 Free PMC article. Chinese.

4

[Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].

Cheng Y, Li H, Zhao D, Han Q, Liu Y, Liu X, Ma L, Liu J. Cheng Y, et al. Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):592-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25430025 Chinese.

5

A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases.

Liu Y, Liu XH, Wang Y, Zhu J, Xin Y, Niu K, Wang S, Cheng Y. Liu Y, et al. Among authors: liu xh. Cancer Biol Ther. 2017 Sep 2;18(9):670-675. doi: 10.1080/15384047.2017.1360450. Epub 2017 Aug 16. Cancer Biol Ther. 2017. PMID: 28812423 Free PMC article.

6

[Disparities of EGFR mutations between Biopsy and Rebiopsy in Non-small Cell Lung Cancer Patients].

Li H, Yan S, Liu X, Liu Y, Ma L, Wang Y, Liu Y, Cheng Y. Li H, et al. Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):821-827. doi: 10.3779/j.issn.1009-3419.2018.11.03. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30454543 Free PMC article. Chinese.

7

Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer.

Lan S, Li H, Liu Y, Ma L, Liu X, Liu Y, Yan S, Cheng Y. Lan S, et al. Lung Cancer. 2019 Jun;132:154-156. doi: 10.1016/j.lungcan.2019.04.025. Epub 2019 Apr 28. Lung Cancer. 2019. PMID: 31054778 No abstract available.

8

Erratum to "Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer" [Lung Cancer 132 (June) (2019) 154-156].

Lan S, Li H, Liu Y, Ma L, Liu X, Liu Y, Yan S, Cheng Y. Lan S, et al. Lung Cancer. 2019 Dec;138:142. doi: 10.1016/j.lungcan.2019.08.021. Epub 2019 Sep 5. Lung Cancer. 2019. PMID: 31493933 No abstract available.

9

Zhang L, Bai L, Liu X, Liu Y, Li S, Liu J, Zhang S, Yang C, Ren X, Cheng Y. Zhang L, et al. Thorac Cancer. 2020 May;11(5):1170-1179. doi: 10.1111/1759-7714.13370. Epub 2020 Mar 5. Thorac Cancer. 2020. PMID: 32134200 Free PMC article.

10

Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors.

Cheng Y, Ma L, Liu Y, Zhu J, Xin Y, Liu X, Wang Y, Zhang T, Yang C, Wang S, Cui H, Zhang L, Dai J, Shao L, Lin J, Ye J, Liu H. Cheng Y, et al. Lung Cancer. 2020 Jul;145:63-70. doi: 10.1016/j.lungcan.2020.04.004. Epub 2020 Apr 17. Lung Cancer. 2020. PMID: 32408134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,381 results

Search Page

Filters